首頁
Eli Lilly and Company

11月 2025Eli Lilly and Company的市場佔有率分析

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

健康 > 生物技術和製藥

域名lilly.ca

成立年份1876

僱員> 10001

年度營收> $1B

Eli Lilly and Company

Eli Lilly and Company（包含公司地區）

lilly.ca

查看更多網站流量與參與度資訊

Eli Lilly and Company截至 11月 2025 的總收入為 > 1B

Eli Lilly and Company 熱門網域產生的總收入

Eli Lilly and Company 熱門網域 3 年內的總收入

Eli Lilly and Company 熱門網域的總收入

lilly.ca> 1B

透過銷售情報查看更多內容

11月 2025Eli Lilly and Company的股票價格

Eli Lilly and Company 股票交易代碼 #LLY。以下是截至 11月 2025Eli Lilly and Company 過去 12 個月的股票績效

Eli Lilly and Company的熱門網域總造訪量

了解Eli Lilly and Company市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Eli Lilly and Company的熱門網域平均造訪時長

分析Eli Lilly and Company參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Eli Lilly and Company的熱門網域平均頁面瀏覽量

了解Eli Lilly and Company如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Eli Lilly and Company按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

lilly-pharma.de公司名Eli Lilly and Company僱員> 10001總部美國, 馬薩諸塞州, Cambridge年度營收> $1B訪問總量--健康 > 生物技術和製藥

使用的熱門技術Eli Lilly and Company

这些是Eli Lilly and Company顶级域名使用的行业网站技术

行動裝置 (3)

Meta Viewport

付費廣告 (2)

DoubleClick

招募 (2)

IBM Kenexa

音訊視訊媒體 (1)

Kaltura

更多技術

4

檢視所有

新聞與訊號來自Eli Lilly and Company

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Eli Lilly and Company launches online portal.Following pharmaceutical company Eli Lilly's announcement of the launch of an online portal to connect consumers to its anti-obesity drugs, interest in weight loss medication has spiked, taking the internet by storm.

新聞Eli Lilly and Company partners with University of Toronto.The anniversary aligns with the final year of centennial celebrations when Eli Lilly partnered with the University of Toronto to make a safe, stable, and reliable supply of insulin, widely available in North America.

新聞Eli Lilly and Company launches Omvoh.TORONTO, Oct. 17, 2023 /CNW/ - Eli Lilly Canada Inc. announced today that Omvoh (mirikizumab) is now available in Canada for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, loss of response, or were intolerant to conventional therapy, a biologic treatment, or a Janus kinase (JAK) inhibitor.